title: The inhibition of Candida-albicans-secreted aspartic proteases by three different HIV protease inhibitors.
authors.affiliation: Service de Dermatologie/DHURDV, Centre Hospitalier Universitaire Vaudois, Lausanne, Suisse. Monod@chuv.hospvd.ch
authors.forename: M
authors.initials: M
authors.lastname: Monod
authors.forename: M
authors.initials: M
authors.lastname: Borg-von Zepelin
authors.forename: A
authors.initials: A
authors.lastname: Telenti
authors.forename: D
authors.initials: D
authors.lastname: Sanglard
mesh_terms: D016282:Aspartic Acid Endopeptidases / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D002176:Candida albicans / Q000201:enzymology*; D002177:Candidiasis / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D006801:Humans; D019469:Indinavir / Q000494:pharmacology; D007527:Isoenzymes / Q000235:genetics / Q000378:metabolism; D010843:Pichia / Q000235:genetics; D011993:Recombinant Fusion Proteins / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D019438:Ritonavir / Q000494:pharmacology; D019258:Saquinavir / Q000494:pharmacology
chemical_list: D017320:HIV Protease Inhibitors; D007527:Isoenzymes; D011993:Recombinant Fusion Proteins; D019469:Indinavir; D016282:Aspartic Acid Endopeptidases; D019258:Saquinavir; D019438:Ritonavir